UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The proteasome and proteasome inhibitors in multiple myeloma

Cancer and metastasis reviews, 2017-12, Vol.36 (4), p.561-584

2017

Volltextzugriff (PDF)

Ubiquitin–proteasome system (UPS) as a target for anticancer treatment

Archives of Pharmacal Research, 2020, 43(11), , pp.1144-1161

2020

Volltextzugriff (PDF)

Positioning of proteasome inhibitors in therapy of solid malignancies

Cancer chemotherapy and pharmacology, 2018-02, Vol.81 (2), p.227-243

2018

Volltextzugriff (PDF)

Proteasome inhibition protects blood-brain barrier P-glycoprotein and lowers Aβ brain levels in an Alzheimer's disease model

Fluids and barriers of the CNS, 2023-10, Vol.20 (1), p.70-70, Article 70

2023

Volltextzugriff (PDF)

Targeting the ubiquitin-proteasome system for cancer treatment: discovering novel inhibitors from nature and drug repurposing

Cancer and metastasis reviews, 2017-12, Vol.36 (4), p.717-736

2017

Volltextzugriff (PDF)

role of the proteasome in the generation of MHC class I ligands and immune responses

Cellular and molecular life sciences : CMLS, 2011-05, Vol.68 (9), p.1491-1502

2011

Volltextzugriff (PDF)

Fibroblast growth factor-21 alleviates proteasome injury via activation of autophagy flux in Parkinson’s disease

Experimental brain research, 2024-01, Vol.242 (1), p.25-32

2024

Volltextzugriff (PDF)

The proteostasis guardian HSF1 directs the transcription of its paralog and interactor HSF2 during proteasome dysfunction

Cellular and molecular life sciences : CMLS, 2021-02, Vol.78 (3), p.1113-1129

2021

Volltextzugriff (PDF)

Teclistamab: First Approval

Drugs (New York, N.Y.), 2022-11, Vol.82 (16), p.1613-1619

Kang, Connie

2022

Volltextzugriff (PDF)

A phase I study to repurpose disulfiram in combination with temozolomide to treat newly diagnosed glioblastoma after chemoradiotherapy

Journal of neuro-oncology, 2016-06, Vol.128 (2), p.259-266

2016

Volltextzugriff (PDF)

The Role of the Ubiquitin Proteasome System in Glioma: Analysis Emphasizing the Main Molecular Players and Therapeutic Strategies Identified in Glioblastoma Multiforme

Molecular neurobiology, 2021-07, Vol.58 (7), p.3252-3269

Maksoud, Semer

2021

Volltextzugriff (PDF)

Bortezomib Inhibits Open Configurations of the 20S Proteasome

Journal of the American Society for Mass Spectrometry, 2024-06, Vol.35 (6), p.1063-1068

2024

Volltextzugriff (PDF)

Ixazomib: First Global Approval

Drugs (New York, N.Y.), 2016-03, Vol.76 (3), p.405-411

Shirley, Matt

2016

Volltextzugriff (PDF)

A Comprehensive Study on the Anti-cancer Effects of Quercetin and Its Epigenetic Modifications in Arresting Progression of Colon Cancer Cell Proliferation

Archivum Immunologiae et Therapiae Experimentalis, 2023-12, Vol.71 (1), p.6-6, Article 6

2023

Volltextzugriff (PDF)

Proteolysis-targeting chimeras (PROTACs) in cancer therapy

Molecular cancer, 2022-04, Vol.21 (1), p.99-99, Article 99

2022

Volltextzugriff (PDF)

p62 links the autophagy pathway and the ubiqutin-proteasome system upon ubiquitinated protein degradation

Cellular & molecular biology letters, 2016-12, Vol.21 (1), p.29-29, Article 29

2016

Volltextzugriff (PDF)

The recognition of ubiquitinated proteins by the proteasome

Cellular and Molecular Life Sciences, 2016-09, Vol.73 (18), p.3497-3506

2016

Volltextzugriff (PDF)

The 26 S proteasome in Entamoeba histolytica: divergence of the substrate binding pockets from host proteasomes

BMC research notes, 2024-08, Vol.17 (1), p.216-9, Article 216

2024

Volltextzugriff (PDF)

The role of PSMB5 in sodium arsenite–induced oxidative stress in L-02 cells

Cell stress & chaperones, 2020-05, Vol.25 (3), p.533-540

2020

Volltextzugriff (PDF)

MG132 dramatically reduces SAA expression in chicken hepatocellular carcinoma cells at the transcript level independent of its endogenous promoter

Molecular biology reports, 2024-12, Vol.51 (1), p.770, Article 770

2024

Volltextzugriff (PDF)

Syrbactin-class dual constitutive- and immuno-proteasome inhibitor TIR-199 impedes myeloma-mediated bone degeneration in vivo

Bioscience reports, 2022-02, Vol.42 (2), p.1

2022

Volltextzugriff (PDF)

Mechanisms of preferential bone formation in myeloma bone lesions by proteasome inhibitors

International journal of hematology, 2023-07, Vol.118 (1), p.88-98

2023

Volltextzugriff (PDF)

ProEnd: a comprehensive database for identifying HbYX motif-containing proteins across the tree of life

BMC genomics, 2024-10, Vol.25 (1), p.951-15, Article 951

2024

Volltextzugriff (PDF)

Oxidative and salt stresses alter the 26S proteasome holoenzyme and associated protein profiles in Arabidopsis thaliana

BMC plant biology, 2021-10, Vol.21 (1), p.486-486, Article 486

2021

Volltextzugriff (PDF)

Mitigated viral myocarditis in A/J mice by the immunoproteasome inhibitor ONX 0914 depends on inhibition of systemic inflammatory responses in CoxsackievirusB3 infection

Basic research in cardiology, 2021-12, Vol.116 (1), p.7, Article 7

2021

Volltextzugriff (PDF)

1 – 25 von 3.478

Suche als RSS-Feed

Aktive Filter

SprachePolnisch

KollektionSpringerLink Journals - AutoHoldings

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(3.423)
Mit Volltextzugriff
(3.441)

Publikationsform

Artikel
(3.478)

Sprache

Englisch
(3.458)
Deutsch
(17)
Russisch
(3)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(3.172)
Life Sciences & Biomedicine
(3.153)
Humans
(1.752)
Proteins
(1.438)
Biomedical And Life Sciences
(1.328)
Proteasomes
(1.290)
Animals
(1.253)
Cell Biology
(1.013)
Ubiquitin
(931)
Biochemistry & Molecular Biology
(878)
Proteasome Endopeptidase Complex - Metabolism
(870)
Life Sciences
(800)
Biomedicine
(789)
Oncology
(716)
Biochemistry
(628)
Apoptosis
(626)
Proteasome
(595)
Gene Expression
(570)
Mice
(492)
Proteasome Inhibitors
(485)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Springer journals
(3.478)
MEDLINE
(2.568)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(2.126)
Ingenta.com
(1.757)
Journals@Ovid Complete
(1.375)
EZB Electronic Journals Library
(1.316)
IngentaConnect Journals
(754)
Nexis Uni
(290)
Single Journals
(157)
JSTOR
(73)
Wiley Online Library Journals Frontfile Complete
(52)
SAGE Complete
(37)
De Gruyter journals
(31)
Taylor & Francis Journals
(31)
SpringerLink Series
(20)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(9)
Taylor & Francis Journals Complete
(8)
De Gruyter Open Access Books
(5)
Brill Online Journals
(4)
Nature
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Cellular And Molecular Life Sciences : Cmls
(159)
Molecular Biology Reports
(103)
Molecular Neurobiology
(100)
Bmc Cancer
(76)
Cellular And Molecular Life Sciences
(76)
Apoptosis
(70)
Molecular And Cellular Biochemistry
(60)
Molecular Cancer
(55)
Journal Of Translational Medicine
(50)
Bmc Genomics
(45)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(49)
... seit 30 Tagen
(11)

Menü

Weitere Dienste

Einstellungen

The proteasome and proteasome inhibitors in multiple myeloma

Ubiquitin–proteasome system (UPS) as a target for anticancer treatment

Positioning of proteasome inhibitors in therapy of solid malignancies

Proteasome inhibition protects blood-brain barrier P-glycoprotein and lowers Aβ brain levels in an Alzheimer's disease model

Targeting the ubiquitin-proteasome system for cancer treatment: discovering novel inhibitors from nature and drug repurposing

role of the proteasome in the generation of MHC class I ligands and immune responses

Fibroblast growth factor-21 alleviates proteasome injury via activation of autophagy flux in Parkinson’s disease

The proteostasis guardian HSF1 directs the transcription of its paralog and interactor HSF2 during proteasome dysfunction

Teclistamab: First Approval

A phase I study to repurpose disulfiram in combination with temozolomide to treat newly diagnosed glioblastoma after chemoradiotherapy

The Role of the Ubiquitin Proteasome System in Glioma: Analysis Emphasizing the Main Molecular Players and Therapeutic Strategies Identified in Glioblastoma Multiforme

Bortezomib Inhibits Open Configurations of the 20S Proteasome

Ixazomib: First Global Approval

A Comprehensive Study on the Anti-cancer Effects of Quercetin and Its Epigenetic Modifications in Arresting Progression of Colon Cancer Cell Proliferation

Proteolysis-targeting chimeras (PROTACs) in cancer therapy

p62 links the autophagy pathway and the ubiqutin-proteasome system upon ubiquitinated protein degradation

The recognition of ubiquitinated proteins by the proteasome

The 26 S proteasome in Entamoeba histolytica: divergence of the substrate binding pockets from host proteasomes

The role of PSMB5 in sodium arsenite–induced oxidative stress in L-02 cells

MG132 dramatically reduces SAA expression in chicken hepatocellular carcinoma cells at the transcript level independent of its endogenous promoter

Syrbactin-class dual constitutive- and immuno-proteasome inhibitor TIR-199 impedes myeloma-mediated bone degeneration in vivo

Mechanisms of preferential bone formation in myeloma bone lesions by proteasome inhibitors

ProEnd: a comprehensive database for identifying HbYX motif-containing proteins across the tree of life

Oxidative and salt stresses alter the 26S proteasome holoenzyme and associated protein profiles in Arabidopsis thaliana

Mitigated viral myocarditis in A/J mice by the immunoproteasome inhibitor ONX 0914 depends on inhibition of systemic inflammatory responses in CoxsackievirusB3 infection

Aktive Filter

Suchergebnisse filtern